Article info
Clinical and epidemiological research
Concise report
Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: the MIRAR Study
- Correspondence to Dr Juan J Gomez-Reino, Department of Rheumatology Unit, Hospital Clinico Universitario, Santiago de Compostela, Santiago, Spain; juan.jesus.gomez-reino.carnota{at}sergas.es
Citation
Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: the MIRAR Study
Publication history
- Received January 11, 2012
- Accepted May 31, 2012
- First published June 26, 2012.
Online issue publication
October 31, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions